Form 4: Colgate-Palmolive Director Acquires Shares Through Deferred Compensation Plan
SEC Form 4 Filing
Director Lorrie M Norrington acquired 258 shares of Colgate-Palmolive common stock at $91.99 per share on April 1, 2025, through a deferred compensation plan.
Summary
- On April 1, 2025, Lorrie M Norrington, a director of Colgate-Palmolive, acquired 258 shares of common stock.
- The acquisition was made through the Deferred Compensation Plan for Non-Employee Directors.
- The price per share was $91.99.
- Following the transaction, Norrington directly owns 36,002 shares of Colgate-Palmolive common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director's participation in the deferred compensation plan suggests confidence in the company's stock. However, it's a routine transaction.
Positives
- The director's participation in the Deferred Compensation Plan demonstrates confidence in the company's future.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's sentiment towards the company's prospects. It is common for directors to receive shares as part of their compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a standard part of director compensation.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of transaction: Acquisition of 258 shares of common stock. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Colgate-Palmolive, Director, Share Acquisition, Deferred Compensation Plan, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.